Effects of an intervention to improve evidence-based care for people with diabetes and cardiovascular disease across sex, race, and ethnicity subgroups: insights from …
M Tannu, L Kaltenbach, NJ Pagidipati, DK McGuire… - Circulation, 2024 - ahajournals.org
BACKGROUND: Results from the COORDINATE-Diabetes trial (Coordinating Cardiology
Clinics Randomized Trial of Interventions to Improve Outcomes-Diabetes) demonstrated that …
Clinics Randomized Trial of Interventions to Improve Outcomes-Diabetes) demonstrated that …
Coordinated care to optimize cardiovascular preventive therapies in type 2 diabetes: a randomized clinical trial
NJ Pagidipati, AJ Nelson, LA Kaltenbach, M Leyva… - JAMA, 2023 - jamanetwork.com
Importance Evidence-based therapies to reduce atherosclerotic cardiovascular disease risk
in adults with type 2 diabetes are underused in clinical practice. Objective To assess the …
in adults with type 2 diabetes are underused in clinical practice. Objective To assess the …
Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE)–Diabetes: rationale and design
Several medications that are proven to reduce cardiovascular events exist for individuals
with type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease, however …
with type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease, however …
Gaps in evidence‐based therapy use in insured patients in the united states with type 2 diabetes mellitus and atherosclerotic cardiovascular disease
AJ Nelson, M Ardissino, K Haynes… - Journal of the …, 2021 - Am Heart Assoc
Background Evidence‐based therapies are generally underused for cardiovascular risk
reduction; however, less is known about contemporary patients with type 2 diabetes mellitus …
reduction; however, less is known about contemporary patients with type 2 diabetes mellitus …
Opportunities for improving use of evidence‐based therapy in patients with type 2 diabetes and cardiovascular disease
Evidence‐based therapy that target hyperlipidemia, hypertension, smoking cessation, and
weight loss have demonstrated significant benefits in reducing cardiovascular risks and …
weight loss have demonstrated significant benefits in reducing cardiovascular risks and …
Lessons Learned From a Patient‐Centered, Team‐Based Intervention for Patients With Type 2 Diabetes at High Cardiovascular Risk: Year 1 Results From the …
IJ Neeland, SG Al‐Kindi, N Tashtish… - Journal of the …, 2022 - Am Heart Assoc
Background The care for patients with type 2 diabetes necessitates a multidisciplinary team
approach to reduce cardiovascular risk, but implementation of effective integrated strategies …
approach to reduce cardiovascular risk, but implementation of effective integrated strategies …
The diabetes cardiovascular outcomes trials and racial and ethnic minority enrollment: impact, barriers, and potential solutions
MR Sinclair, M Ardehali, CJ Diamantidis… - Frontiers in Public …, 2024 - frontiersin.org
Type 2 diabetes (T2D) affects millions of individuals worldwide and is a well-documented
risk factor for cardiovascular (CV) disease and chronic kidney disease, both of which are …
risk factor for cardiovascular (CV) disease and chronic kidney disease, both of which are …
Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials
DL Mount, P Feeney, AN Fabricatore, M Coday… - Clinical …, 2009 - journals.sagepub.com
Background Comparing findings from separate trials is necessary to choose among
treatment options, however differences among study cohorts may impede these …
treatment options, however differences among study cohorts may impede these …
[HTML][HTML] Second-year results from CINEMA: A novel, patient-centered, team-based intervention for patients with Type 2 diabetes or prediabetes at high cardiovascular …
IJ Neeland, B Bourges-Sevenier, JE Dazard… - American Journal of …, 2024 - Elsevier
Background The care for patients with type 2 diabetes mellitus (T2DM) necessitates a
multidisciplinary team approach to reduce cardiovascular (CV) risk but implementation of …
multidisciplinary team approach to reduce cardiovascular (CV) risk but implementation of …
Use of lipid-, blood pressure–, and glucose-lowering pharmacotherapy in patients with type 2 diabetes and atherosclerotic cardiovascular disease
AJ Nelson, EC O'Brien, LA Kaltenbach… - JAMA Network …, 2022 - jamanetwork.com
Importance Based on contemporary estimates in the US, evidence-based therapies for
cardiovascular risk reduction are generally underused among patients with type 2 diabetes …
cardiovascular risk reduction are generally underused among patients with type 2 diabetes …